{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:18:25Z","timestamp":1790817505204,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Clinical medical center of Fuzhou, Fujian, P.R.C","award":["201808310"],"award-info":[{"award-number":["201808310"]}]},{"name":"the Basic and Clinical Research of Rare Disease","award":["ZD-2019-01"],"award-info":[{"award-number":["ZD-2019-01"]}]},{"name":"Social Development Projects of Fuzhou, Fujian, P.R.C","award":["2019-S-80"],"award-info":[{"award-number":["2019-S-80"]}]},{"name":"the Science and Technology Planning Project of Fuzhou, Fujian, P.R.C","award":["2021-S-197"],"award-info":[{"award-number":["2021-S-197"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Heterozygous loss-of-function variants in the\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene cause short stature with nonspecific skeletal abnormalities and account for about 2\u2009~\u20096% of idiopathic short stature. This study aimed to analyze and identify pathogenic variants in the\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene and explore the therapeutic response to recombinant growth hormone (rhGH).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>NPR2<\/jats:italic>\n                      was sequenced in three Chinese Han patients with short stature via exome sequencing. In vitro functional experiments, homology modeling and molecular docking analysis of variants were performed to examine putative protein changes and the pathogenicity of the variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      Three patients received rhGH therapy for two years, and two\n                      <jats:italic>NPR2<\/jats:italic>\n                      heterozygous variants were identified in three unrelated cases: c.1579\u00a0C\u2009&gt;\u2009T,p.Leu527Phe in patient 1 and c.2842dupC,p.His948Profs*5 in patient 2. Subsequently, a small gene model was constructed, and transcriptional analysis of the synonymous variant (c.2643G\u2009&gt;\u2009A) was performed in patient 3, which revealed the deletion of exon 17 and the premature formation of a stop codon (p.His840Gln*). Functional studies showed that both NPR2 variants, His948Profs*5 and His840Gln*, failed to produce cGMP in the homozygous state. Furthermore, the Leu527Phe variant of NPR2 was almost unresponsive to the stimulatory effect of ATP on CNP-dependent guanylyl cyclase activity. This loss of response to ATP has not been previously reported. The average age of patients at the start of treatment was 6.5\u2009\u00b1\u20091.8 years old, and their height increased by 1.59\u2009\u00b1\u20090.1 standard deviation score after 2 years of treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this report, two novel variants in\n                      <jats:italic>NPR2<\/jats:italic>\n                      gene were described. Our findings broaden the genotypic spectrum of\n                      <jats:italic>NPR2<\/jats:italic>\n                      variants in individuals with short stature and provid insights into the efficacy of rhGH in these patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02757-8","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T10:03:59Z","timestamp":1690452239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH"],"prefix":"10.1186","volume":"18","author":[{"given":"Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunteng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4114-7706","authenticated-orcid":false,"given":"Ruimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"2757_CR1","doi-asserted-by":"crossref","unstructured":"Argente J. Challenges in the management of short stature. Horm Res Paediatr 2016;85(1).","DOI":"10.1159\/000442350"},{"issue":"12","key":"2757_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrendo.2015.165","volume":"11","author":"J Baron","year":"2015","unstructured":"Baron J, S\u00e4vendahl L, De Luca F, et al. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol. 2015;11(12):735\u201346.","journal-title":"Nat Rev Endocrinol"},{"key":"2757_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells12010008","volume":"11","author":"Q Li","year":"2022","unstructured":"Li Q, Fan X, Lu W, et al. Novel NPR2 gene mutations affect chondrocytes function via ER stress in short stature. Cells. 2022;11:8.","journal-title":"Cells"},{"issue":"2","key":"2757_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1210\/clinem\/dgaa842","volume":"106","author":"X Ke","year":"2021","unstructured":"Ke X, Liang H, Miao H, et al. Clinical characteristics of short-stature patients with an NPR2 mutation and the therapeutic response to rhGH. J Clin Endocrinol Metab. 2021;106(2):431\u201341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2757_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1210\/er.2005-0014","volume":"27","author":"LR Potter","year":"2006","unstructured":"Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27(1):47\u201372.","journal-title":"Endocr Rev"},{"issue":"3","key":"2757_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2007.06.014","volume":"92","author":"K Pejchalova","year":"2007","unstructured":"Pejchalova K, Krejci P, Wilcox WR. C-natriuretic peptide: an important regulator of cartilage. Mol Genet Metab. 2007;92(3):210\u20135.","journal-title":"Mol Genet Metab"},{"issue":"Pt 21","key":"2757_CR7","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1242\/jcs.02618","volume":"118","author":"P Krejci","year":"2005","unstructured":"Krejci P, Masri B, Fontaine V, et al. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci. 2005;118(Pt 21):5089\u2013100.","journal-title":"J Cell Sci"},{"issue":"1","key":"2757_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12020-020-02362-w","volume":"71","author":"MF Faienza","year":"2021","unstructured":"Faienza MF, Chiarito M, Brunetti G, D\u2019Amato G. Growth plate gene involment and isolated short stature. Endocrine. 2021;71(1):28\u201334.","journal-title":"Endocrine"},{"key":"2757_CR9","doi-asserted-by":"crossref","unstructured":"Miyazaki Y, Ichimura A, Kitayama R et al. C-type natriuretic peptide facilitates autonomic ca entry in growth plate chondrocytes for stimulating bone growth. Elife 2022;11.","DOI":"10.7554\/eLife.71931"},{"key":"2757_CR10","doi-asserted-by":"crossref","unstructured":"Stavber L, Gaia MJ, Hovnik T et al. Heterozygous variants in idiopathic short stature. Genes (Basel) 2022;13(6).","DOI":"10.3390\/genes13061065"},{"issue":"7","key":"2757_CR11","doi-asserted-by":"publisher","first-page":"e2711","DOI":"10.1210\/clinem\/dgab088","volume":"106","author":"L Lin","year":"2021","unstructured":"Lin L, Li M, Luo J, et al. A high proportion of novel ACAN mutations and their prevalence in a large cohort of chinese short stature children. J Clin Endocrinol Metab. 2021;106(7):e2711\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2757_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1507\/endocrj.EJ12-0110","volume":"59","author":"T Isojima","year":"2012","unstructured":"Isojima T, Shimatsu A, Yokoya S, et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal japanese population using the LMS method. Endocr J. 2012;59(9):771\u201380.","journal-title":"Endocr J"},{"issue":"1","key":"2757_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13023-019-1219-x","volume":"14","author":"H Shangguan","year":"2019","unstructured":"Shangguan H, Su C, Ouyang Q, et al. Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature. Orphanet J Rare Dis. 2019;14(1):255.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2757_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, et al. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37(6):564\u20139.","journal-title":"Hum Mutat"},{"key":"2757_CR15","doi-asserted-by":"publisher","first-page":"736988","DOI":"10.3389\/fgene.2022.736988","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Chen Q, Zhu Y, et al. MAP3K1 variant causes hyperactivation of Wnt4\/\u03b2-Catenin\/FOXL2 signaling contributing to 46,XY Disorders\/Differences of Sex Development. Front Genet. 2022;13:736988.","journal-title":"Front Genet"},{"issue":"1","key":"2757_CR16","doi-asserted-by":"publisher","first-page":"e1003440","DOI":"10.1371\/journal.pcbi.1003440","volume":"10","author":"J Bendl","year":"2014","unstructured":"Bendl J, Stourac J, Salanda O, et al. PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol. 2014;10(1):e1003440.","journal-title":"PLoS Comput Biol"},{"key":"2757_CR17","doi-asserted-by":"crossref","unstructured":"Micale L, Morlino S, Schirizzi A et al. Exon-trapping assay improves clinical interpretation of COL11A1 and COL11A2 intronic variants in Stickler Syndrome Type 2 and Otospondylomegaepiphyseal Dysplasia. Genes (Basel). 2020;11(12).","DOI":"10.3390\/genes11121513"},{"key":"2757_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-2946-3-8","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle NM, Vandermeersch T, Flynn CJ, Maguire AR, Hutchison GR. Confab - systematic generation of diverse low-energy conformers. J Cheminform. 2011;3:8.","journal-title":"J Cheminform"},{"issue":"2","key":"2757_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"Suppl 4","key":"2757_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-13-S4-S2","volume":"13","author":"E Bramucci","year":"2012","unstructured":"Bramucci E, Paiardini A, Bossa F, Pascarella S. PyMod: sequence similarity searches, multiple sequence-structure alignments, and homology modeling within PyMOL. BMC Bioinformatics. 2012;13(Suppl 4):2.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"2757_CR21","doi-asserted-by":"publisher","first-page":"e1004586","DOI":"10.1371\/journal.pcbi.1004586","volume":"11","author":"PA Ravindranath","year":"2015","unstructured":"Ravindranath PA, Forli S, Goodsell DS, Olson AJ, Sanner MF. AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility. PLoS Comput Biol. 2015;11(12):e1004586.","journal-title":"PLoS Comput Biol"},{"issue":"W1","key":"2757_CR22","doi-asserted-by":"publisher","first-page":"W350","DOI":"10.1093\/nar\/gky300","volume":"46","author":"CH Rodrigues","year":"2018","unstructured":"Rodrigues CH, Pires DE, Ascher DB. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 2018;46(W1):W350\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2757_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/jpem-2021-0332","volume":"35","author":"K Yuan","year":"2022","unstructured":"Yuan K, Chen J, Chen Q, et al. Gene variants in familial short stature: a single-center study. J Pediatr Endocrinol Metab. 2022;35(2):185\u201390.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"10","key":"2757_CR24","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1016\/j.ejmech.2010.07.034","volume":"45","author":"PK Ojha","year":"2010","unstructured":"Ojha PK, Roy K. Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials. Eur J Med Chem. 2010;45(10):4645\u201356.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"2757_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000365049","volume":"82","author":"GA Vasques","year":"2014","unstructured":"Vasques GA, Arnhold IJP, Jorge AAL. Role of the natriuretic peptide system in normal growth and growth disorders. Horm Res Paediatr. 2014;82(4):222\u20139.","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"2757_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/hmg\/ddy428","volume":"28","author":"K Yamamoto","year":"2019","unstructured":"Yamamoto K, Kawai M, Yamazaki M, et al. CREB activation in hypertrophic chondrocytes is involved in the skeletal overgrowth in epiphyseal chondrodysplasia Miura type caused by activating mutations of natriuretic peptide receptor B. Hum Mol Genet. 2019;28(7):1183\u201398.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2757_CR27","doi-asserted-by":"publisher","first-page":"E1988","DOI":"10.1210\/jc.2013-2358","volume":"98","author":"SE Hannema","year":"2013","unstructured":"Hannema SE, van Duyvenvoorde HA, Premsler T, et al. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities. J Clin Endocrinol Metab. 2013;98(12):E1988\u201398.","journal-title":"J Clin Endocrinol Metab"},{"key":"2757_CR28","doi-asserted-by":"publisher","first-page":"823861","DOI":"10.3389\/fgene.2022.823861","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Wang M, Jiao Z, et al. Novel loss-of-function mutations in cause Acromesomelic Dysplasia, Maroteaux Type. Front Genet. 2022;13:823861.","journal-title":"Front Genet"},{"issue":"10","key":"2757_CR29","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1210\/jc.2007-1101","volume":"92","author":"R Hachiya","year":"2007","unstructured":"Hachiya R, Ohashi Y, Kamei Y, et al. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development. J Clin Endocrinol Metab. 2007;92(10):4009\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"49","key":"2757_CR30","doi-asserted-by":"publisher","first-page":"48880","DOI":"10.1074\/jbc.M308680200","volume":"278","author":"N Tamura","year":"2003","unstructured":"Tamura N, Garbers DL. Regulation of the guanylyl cyclase-B receptor by alternative splicing. J Biol Chem. 2003;278(49):48880\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"2757_CR31","doi-asserted-by":"publisher","first-page":"E1636","DOI":"10.1210\/jc.2013-2142","volume":"98","author":"GA Vasques","year":"2013","unstructured":"Vasques GA, Amano N, Docko AJ, et al. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. J Clin Endocrinol Metab. 2013;98(10):E1636\u201344.","journal-title":"J Clin Endocrinol Metab"},{"key":"2757_CR32","first-page":"7658496","volume":"2018","author":"M Jacob","year":"2018","unstructured":"Jacob M, Menon S, Botti C, Marshall I. Heterozygous mutation in two family members with short stature and skeletal dysplasia. Case Rep Endocrinol. 2018;2018:7658496.","journal-title":"Case Rep Endocrinol"},{"issue":"1","key":"2757_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/jpem-2016-0280","volume":"30","author":"GA Vasques","year":"2017","unstructured":"Vasques GA, Hisado-Oliva A, Funari MFA, et al. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2. J Pediatr Endocrinol Metab. 2017;30(1):111\u20136.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2757_CR34","doi-asserted-by":"crossref","unstructured":"Plachy L, Dusatkova P, Maratova K et al. NPR2 variants are frequent among children with familiar short stature and respond well to growth hormone therapy. J Clin Endocrinol Metab 2020;105(3).","DOI":"10.1210\/clinem\/dgaa037"},{"key":"2757_CR35","doi-asserted-by":"crossref","unstructured":"Hanley PC, Kanwar HS, Martineau C, Levine MA. Short stature is progressive in patients with heterozygous NPR2 mutations. J Clin Endocrinol Metab 2020;105(10).","DOI":"10.1210\/clinem\/dgaa491"},{"issue":"7","key":"2757_CR36","first-page":"487","volume":"47","author":"H Li","year":"2009","unstructured":"Li H, Ji C-Y, Zong X-N, Zhang Y-Q. [Height and weight standardized growth charts for chinese children and adolescents aged 0 to 18 years]. Zhonghua Er Ke Za Zhi. 2009;47(7):487\u201392.","journal-title":"Zhonghua Er Ke Za Zhi"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02757-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02757-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T18:17:33Z","timestamp":1702837053000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02757-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2757"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02757-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1991300\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"23 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Fuzhou Children\u2019s Hospital of Fujian Medical University (approval number 201921) and was conducted in agreement with the Declaration of Helsinki. Written informed consent was obtained from their parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"221"}}